
An initial clinical phase I trial of zzso has been carried out at dose levels of zzso zzso of body surface area using a zzso zzso zzso zzso toxicity was not seen at zzso dose levels less than 2900 zzso At higher doses, zzso and vomiting was nearly zzso Hematologic toxicity zzso by zzso occurred in 12 of 20 patients treated with doses of zzso zzso zzso to 100,000 zzso was not seen in any zzso zzso zzso toxicity zzso by zzso zzso was seen in 15 of 23 patients treated with doses of zzso zzso zzso zzso could be completely prevented by zzso irrigation with zzso zzso solution, 2000 zzso With careful attention to zzso zzso toxicity was largely prevented with blood zzso nitrogen zzso to 30 zzso in only two of 14 patients receiving zzso doses of zzso zzso Another side effect was central nervous system toxicity in seven of 17 patients at doses of zzso zzso For phase II trials a dose of zzso zzso is recommended, with careful attention to the state of zzso in the patient and with the knowledge that zzso irrigation may be necessary for the prevention and/or zzso of zzso zzso 

